Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by JoppeNL

V.GROW

RE:Are they going to give it up..so

I did receive a response a couple if weeks ago. The answer is very...

October 29, 2024

V.GROW

RE:legality

I'm wondering as well. They kept communicating a positive outlook on...

October 18, 2024

V.GROW

RE:RE:RE:RE:RE:RE:Anyone any news????

There must be plenty of duped shareholders from the US or Canada who know how...

August 27, 2024

V.GROW

Comments censored?

Strange that a neutral comment of mine, in which I wonder whether there is no...

August 23, 2024

V.GROW

RE:RE:Anyone any news????

I sincerely hope that someone keeps us foreign shareholders up-to-date on...

August 15, 2024

V.GROW

Anyone any news????

Does anyone out there have any news??

August 14, 2024

V.GROW

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Latest Press Release

I live in the Netherlands so I have no idea how these kinds of things are...

July 6, 2024

V.GROW

RE:Latest Press Release

So much for CO2 GRO then. Has the Board been misleading us all? They surely...

June 24, 2024

V.GROW

RE:RE:RE:RE:RE:RE:RE:Company Update

Yes, the website returned though much simpler that it was. This is a...

May 28, 2024

V.GROW

RE:Company Update

I fully agree. I believe that longtime shareholders are entitled to know what...

May 24, 2024

V.GROW

RE:Company site down...

Not a good sign indeed, although I still find it hard to believe this means...

May 15, 2024

V.GROW

RE:RE:RE:RE:share price

I couldn't agree more with everything you mention, especially the way...

March 6, 2024

V.GROW

RE:RE:New Press Release - CO2 GRO's Technology Receives a Boost from COP28 Sustainable Agriculture Declaration

Like some wealthy oil sheik buying the company @ USD$3.00 / share ;-)

December 14, 2023

V.GROW

RE:1k volume

Kid traders? Unbelievabe, such low trade volumes. Hope this will turn for the...

November 1, 2023

V.GROW

RE:Deep Dive

You would be mad not to keep your shares or not to buy or add to them at the...

September 14, 2023

V.GROW

RE:New investors supplychange fund

Just send Aaron Archibald (VP Sales & Ops) an email with your thoughts. I...

September 12, 2023

V.GROW

RE:A new 150 week low!!

I am convinced that they are not lies. But I have been repeatingly stating...

August 12, 2023

V.GROW

RE:RE:Fins on sedar

What I find even more curious is that CO2 GRO just don't seem to get the...

June 5, 2023

V.GROW

CO2 Gro's communication strategy...or rather the lack of it?

CO2 Gro has a wonderful product for which there is a potentially enormous...

May 17, 2023

V.GROW

RE:VERY ODD

Hi Rainman, Can you explain to me what "Level 2 Quotes" are and...

March 2, 2023

1 2 Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »